-
GMDC's well-attended 'Demo Day' facilitates health innovation at retail
SAN ANTONIO – The Global Market Development Center is infusing both innovation and intelligence into the marketplace to help facilitate the retail self-care opportunity at the 2016 Health Beauty Wellness (HBW16) Marketing Conference, which hosted almost 700 participants, held here.
-
FDA approves Medtronics’ ‘artificial pancreas’ for Type 1 diabetes
SILVER SPRING, Md. — The Food and Drug Administration this week approved a new device that can automatically monitor glucose levels and provide doses of basal insulin for patients 14 years and older with Type 1 diabetes. Medtronic’s MiniMed 670G hybrid closed loop system is often called an ‘artificial pancreas’ because of its ability to adjust insulin levels with little user input.XThis ad will auto-close in 10 seconds